PPCA-03

N/A

Report date: 2024/11/07 14:42:52

Base Information

Drug NamePPCA-03
Drug Alias NamePPCA-03
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmorta Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmorta Bio Inc
Inactive CompaniesN/A
Active IndicationsIschemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A